RhumbLine Advisers’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$193K Buy
46,693
+1,989
+4% +$8.78K ﹤0.01% 3298
2026
Q1
$161K Buy
44,704
+247
+0.6% +$855 ﹤0.01% 3216
2025
Q4
$152K Sell
44,457
-7,694
-15% -$37.3K ﹤0.01% 3301
2025
Q3
$354K Sell
52,151
-1,438
-3% -$11.9K ﹤0.01% 2896
2025
Q2
$730K Buy
53,589
+4,281
+9% +$40.4K ﹤0.01% 2419
2025
Q1
$268K Buy
49,308
+619
+1% +$3.51K ﹤0.01% 2953
2024
Q4
$241K Buy
48,689
+2,814
+6% +$14.8K ﹤0.01% 3099
2024
Q3
$240K Sell
45,875
-1,606
-3% -$9.26K ﹤0.01% 3143
2024
Q2
$326K Buy
+47,481
New +$434K ﹤0.01% 2952

Other funds holding LFMD

RhumbLine Advisers's LFMD Position: Q2 2026 in Review

RhumbLine Advisers increased its LifeMD (LFMD) stake by 4.4% in Q2 2026, buying an estimated $8.78K and bringing the position to 46,693 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #3298.

RhumbLine Advisers first reported a position in LFMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $730K in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • RhumbLine Advisers held 46,693 shares of LifeMD worth $193K as of Q2 2026.
  • RhumbLine Advisers bought 1,989 LifeMD shares in Q2 2026, an estimated $8.78K.
  • LifeMD made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3298 holding.
  • RhumbLine Advisers first reported a position in LifeMD in Q2 2024 and has held it in 9 quarters since.
  • RhumbLine Advisers's LifeMD position peaked at $730K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.